High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris
- 1 December 1995
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 133 (6), 1014-1016
- https://doi.org/10.1111/j.1365-2133.1995.tb06952.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pooled Human IgG Modulates Cytokine Production in Lymphocytes and MonocytesImmunological Reviews, 1994
- Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myelomaThe Lancet, 1994
- Juvenile dermatomyositis: treatment with intravenous gammaglobulinBritish Journal of Dermatology, 1994
- Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion.JCI Insight, 1994
- Immunologically active proteins in intravenous immunoglobulinThe Lancet, 1993
- Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]JCI Insight, 1993
- Effects of intravenous γ-globulin in pemphigusJournal of the American Academy of Dermatology, 1990
- High-dosage intravenous gamma globulin: Therapeutic failure in pemphigus and pemphigoidJournal of the American Academy of Dermatology, 1989
- Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM‐induced antibody synthesis in vitroBritish Journal of Haematology, 1986
- Regulation of the Immune Response by Idiotypic-Antiidiotypic InteractionsNew England Journal of Medicine, 1981